Lioe-Fee de Geus-Oei
0000-0003-1817-2743
231 papers found
Refreshing results…
Performance of 3DOSEM and MAP algorithms for reconstructing low count SPECT acquisitions
The impact of respiratory gated positron emission tomography on clinical staging and management of patients with lung cancer
From Incidentaloma to Oncocytoma: A Role for Hybrid Molecular Imaging in Characterising Renal Masses?
Multivariable normal-tissue complication modeling of acute esophageal toxicity in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy
Evaluating the use of optimally respiratory gated 18F-FDG-PET in target volume delineation and its influence on radiation doses to the organs at risk in non-small-cell lung cancer patients:
Relationship of promising methods in the detection of anthracycline-induced cardiotoxicity in breast cancer patients
Improving the Spatial Alignment in PET/CT Using Amplitude-Based Respiration-Gated PET and Respiration-Triggered CT
Update on F-18-fluoro-deoxy-glucose-PET/computed tomography in nonsmall cell lung cancer:
Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA)
Abstract OT3-2-01: IMPACT: IMaging PAtients for Cancer drug selecTion – Metastatic breast cancer (MBC)
PET in the management of locally advanced and metastatic NSCLC
Multimodality Imaging to Predict Response to Systemic Treatment in Patients with Advanced Colorectal Cancer
New biomarkers for early detection of cardiotoxicity after treatment with docetaxel, doxorubicin and cyclophosphamide
Impact of Optimal Respiratory Gated Positron Emission Tomography on Characterisation of Intra-Tumour Heterogeneity in Lung Cancer Patients
Respiratory gated 18F-FDG-PET/CT improves quantification of metabolic parameters and their correlation with overall survival in patients with pancreatic ductal adenocarcinoma
Effect of respiratory gated positron emission tomography on clinical staging and management of lung cancer
Biological Effects After Discontinuation of VEGFR Inhibitors in Metastatic Renal Cell Cancer
In-treatment assessment of response in locally advanced NSCLC: Paving the way for personalized medicine
Avastin Scintigraphy in Surveillance of Bevacizumab Treatment in a Patient With Neurofibromatosis Type 2
Glucose Metabolism in NSCLC Is Histology-Specific and Diverges the Prognostic Potential of 18FDG-PET for Adenocarcinoma and Squamous Cell Carcinoma
Missing publications? Search for publications with a matching author name.